TY - JOUR
T1 - Hopelessness and suicidal ideation in outpatients with treatment-resistant depression
T2 - Prevalence and impact on treatment outcome
AU - Papakostas, George I.
AU - Petersen, Timothy
AU - Pava, Joel
AU - Masson, Ella
AU - Worthington, John J.
AU - Alpert, Jonathan E.
AU - Fava, Maurizio
AU - Nierenberg, Andrew A.
PY - 2003/7/1
Y1 - 2003/7/1
N2 - Depression and hopelessness are risk factors for suicide. The purpose of this study was to examine the extent of suicidal ideation and hopelessness in outpatients with treatment-resistant depression (TRD) and to study the impact of suicidal ideation and hopelessness on treatment with nortriptyline (NT). The degree of suicidal ideation and hopelessness was assessed during the screen visit with the use of items #3 and #30 of the Hamilton Depression Rating Scale (HAM-D) in 89 patients with TRD who entered a 6-week open trial of NT. Forty of these patients also completed the Beck Hopelessness Index (BHI) during the screen visit. In separate logistic regressions, the scores from the BHI and the two HAM-D items were then tested as predictors of clinical response to the 6-week trial with NT, controlling for the severity of depression. More than half of patients reported thoughts or wishes of death to self and significant hopelessness. A greater degree of hopelessness before treatment in completers, reflected by the score on the HAM-D item #30, predicted response to NT. More than half of patients with prominent hopelessness who completed the trial responded. Patients with TRD are more likely than not to report prominent suicidal ideation and hopelessness. Furthermore, a full 6-week trial of NT, a relatively noradrenergic tricyclic antidepressant, may be particularly useful in patients who have failed to respond to several antidepressants and also report significant hopelessness.
AB - Depression and hopelessness are risk factors for suicide. The purpose of this study was to examine the extent of suicidal ideation and hopelessness in outpatients with treatment-resistant depression (TRD) and to study the impact of suicidal ideation and hopelessness on treatment with nortriptyline (NT). The degree of suicidal ideation and hopelessness was assessed during the screen visit with the use of items #3 and #30 of the Hamilton Depression Rating Scale (HAM-D) in 89 patients with TRD who entered a 6-week open trial of NT. Forty of these patients also completed the Beck Hopelessness Index (BHI) during the screen visit. In separate logistic regressions, the scores from the BHI and the two HAM-D items were then tested as predictors of clinical response to the 6-week trial with NT, controlling for the severity of depression. More than half of patients reported thoughts or wishes of death to self and significant hopelessness. A greater degree of hopelessness before treatment in completers, reflected by the score on the HAM-D item #30, predicted response to NT. More than half of patients with prominent hopelessness who completed the trial responded. Patients with TRD are more likely than not to report prominent suicidal ideation and hopelessness. Furthermore, a full 6-week trial of NT, a relatively noradrenergic tricyclic antidepressant, may be particularly useful in patients who have failed to respond to several antidepressants and also report significant hopelessness.
UR - http://www.scopus.com/inward/record.url?scp=0043125822&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0043125822&partnerID=8YFLogxK
U2 - 10.1097/01.NMD.0000081591.46444.97
DO - 10.1097/01.NMD.0000081591.46444.97
M3 - Article
C2 - 12891091
AN - SCOPUS:0043125822
SN - 0022-3018
VL - 191
SP - 444
EP - 449
JO - Journal of Nervous and Mental Disease
JF - Journal of Nervous and Mental Disease
IS - 7
ER -